|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.59 USD | -0.87% |
|
-7.40% | -8.14% |
| 01-13 | BioMarin Pharmaceuticals Aims for Sustained Growth in 2026, Wedbush Says | MT |
| 01-13 | BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 20.6x | 1.7x | 2.9x | 14.42x | 14.02x | 10.49B | ||
| 0.5% | 0.53% | 17.95x | 2.36x | 4.83x | 12.27x | 14.67x | 75.21B | ||
| -.--% | -.--% | 58.66x | 7.89x | 15.52x | 33.29x | 41.68x | 61.16B | ||
| 0.53% | 0.55% | 44.56x | 4.73x | 7.05x | 23.06x | 30.99x | 58.53B | ||
| 2.63% | 2.86% | 22.43x | 2.8x | 4.09x | 11.88x | 13.71x | 56.54B | ||
| -.--% | -.--% | 15.84x | 1.31x | 2.63x | 8.29x | 9.16x | 24.12B | ||
| -.--% | -.--% | 17.13x | 3.62x | 3.39x | 10.17x | 10.32x | 20.85B | ||
| -.--% | 0.02% | 81.94x | 7.95x | 9.81x | 88.44x | 101.48x | 19.91B | ||
| -.--% | -.--% | -5.19x | 1.92x | 5.92x | -3.49x | -3.29x | 16.34B | ||
| -.--% | -.--% | -22.28x | -7.19x | 32.03x | -32.72x | -31.76x | 14.7B | ||
| -.--% | -.--% | -656.06x | 2.81x | 4.37x | 11.29x | 23.01x | 12.38B | ||
| -.--% | -.--% | -16.19x | - | 582.69x | -15.96x | -16.12x | 10.93B | ||
| -.--% | -.--% | -46.99x | 201.64x | 13.93x | -58.14x | -51.72x | 8.94B | ||
| 3% | 1.94% | 6.06x | 2.52x | 2.75x | 4.12x | 4.16x | 8.48B | ||
| -.--% | -.--% | 42.47x | - | 19.93x | 46.08x | 47.83x | 8.27B | ||
| -.--% | -.--% | -249.34x | - | - | - | - | 8.18B | ||
| 1.5% | 1.81% | 17.24x | 1.17x | 2.05x | 8.49x | 11.3x | 7.63B | ||
| Average | 0.48% | 0.45% | -38.30x | 16.80x | 44.62x | 10.09x | 13.71x | 24.86B | |
| Weighted average by Cap. | 0.6% | 0.63% | 1.81x | 8.02x | 23.24x | 16.15x | 20.48x |
- Stock Market
- Equities
- BMRN Stock
- Sector BioMarin Pharmaceutical Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















